Novartis Ag Adr Stock Market Capitalization

NVS Stock  USD 96.73  0.85  0.89%   
Novartis AG ADR fundamentals help investors to digest information that contributes to Novartis' financial success or failures. It also enables traders to predict the movement of Novartis Stock. The fundamental analysis module provides a way to measure Novartis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novartis stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Novartis Market Capitalization Analysis

Novartis' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Market Cap

 = 

Shares Outstanding

X

Share Price

More About Market Capitalization | All Equity Analysis

Current Novartis Market Capitalization

    
  198.19 B  
Most of Novartis' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Novartis AG ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Novartis Market Capitalization Driver Correlations

Understanding the fundamental principles of building solid financial models for Novartis is extremely important. It helps to project a fair market value of Novartis Stock properly, considering its historical fundamentals such as Market Capitalization. Since Novartis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Novartis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Novartis' interrelated accounts and indicators.
0.660.920.520.710.920.920.7-0.01-0.050.00.880.410.55-0.070.930.750.610.760.98-0.010.830.10.370.26-0.360.190.290.260.040.22
0.660.360.040.70.390.740.260.390.16-0.660.860.750.61-0.440.720.360.240.810.640.510.35-0.490.27-0.35-0.420.60.3-0.290.11-0.1
0.920.360.650.430.990.830.71-0.08-0.060.310.620.260.280.120.770.620.520.470.92-0.260.880.420.250.38-0.27-0.140.170.450.180.29
0.520.040.650.120.690.350.23-0.26-0.210.330.260.04-0.070.10.330.550.410.280.47-0.290.440.460.210.5-0.72-0.160.030.310.10.2
0.710.70.430.120.490.610.450.14-0.14-0.40.880.230.62-0.250.850.730.460.910.680.320.35-0.430.360.15-0.290.580.24-0.05-0.180.09
0.920.390.990.690.490.820.7-0.05-0.120.240.650.270.270.060.80.680.560.540.92-0.180.840.380.310.38-0.36-0.070.20.40.20.27
0.920.740.830.350.610.820.65-0.010.14-0.10.840.430.49-0.120.870.580.360.660.94-0.010.87-0.010.180.09-0.280.140.150.070.020.15
0.70.260.710.230.450.70.65-0.28-0.50.290.530.040.29-0.030.690.460.370.440.77-0.280.80.230.270.210.060.030.110.18-0.030.1
-0.010.39-0.08-0.260.14-0.05-0.01-0.280.22-0.50.080.67-0.06-0.120.08-0.29-0.160.17-0.030.51-0.35-0.160.05-0.53-0.010.20.240.010.76-0.01
-0.050.16-0.06-0.21-0.14-0.120.14-0.50.22-0.21-0.020.190.090.09-0.11-0.2-0.2-0.22-0.080.12-0.03-0.16-0.25-0.170.13-0.18-0.03-0.01-0.010.05
0.0-0.660.310.33-0.40.24-0.10.29-0.5-0.21-0.36-0.54-0.290.74-0.16-0.020.07-0.480.05-0.830.30.85-0.150.650.39-0.77-0.330.75-0.130.54
0.880.860.620.260.880.650.840.530.08-0.02-0.360.490.75-0.270.920.740.590.930.850.280.59-0.290.430.08-0.390.530.37-0.02-0.120.1
0.410.750.260.040.230.270.430.040.670.19-0.540.490.36-0.380.36-0.020.230.480.360.530.11-0.150.35-0.57-0.340.420.51-0.120.58-0.16
0.550.610.28-0.070.620.270.490.29-0.060.09-0.290.750.36-0.250.620.530.630.620.490.360.29-0.350.59-0.04-0.060.520.510.0-0.360.01
-0.07-0.440.120.1-0.250.06-0.12-0.03-0.120.090.74-0.27-0.38-0.25-0.19-0.11-0.03-0.39-0.05-0.750.030.72-0.360.670.48-0.77-0.370.84-0.110.9
0.930.720.770.330.850.80.870.690.08-0.11-0.160.920.360.62-0.190.760.520.830.930.150.69-0.120.420.13-0.310.330.30.110.020.13
0.750.360.620.550.730.680.580.46-0.29-0.2-0.020.74-0.020.53-0.110.760.760.740.680.090.52-0.040.50.52-0.470.320.320.15-0.290.18
0.610.240.520.410.460.560.360.37-0.16-0.20.070.590.230.63-0.030.520.760.580.50.120.350.20.790.41-0.260.330.70.35-0.10.22
0.760.810.470.280.910.540.660.440.17-0.22-0.480.930.480.62-0.390.830.740.580.710.420.38-0.360.510.04-0.530.710.41-0.13-0.040.0
0.980.640.920.470.680.920.940.77-0.03-0.080.050.850.360.49-0.050.930.680.50.71-0.060.870.120.30.22-0.290.110.180.240.040.22
-0.010.51-0.26-0.290.32-0.18-0.01-0.280.510.12-0.830.280.530.36-0.750.150.090.120.42-0.06-0.32-0.710.4-0.63-0.310.760.39-0.580.2-0.56
0.830.350.880.440.350.840.870.8-0.35-0.030.30.590.110.290.030.690.520.350.380.87-0.320.270.070.31-0.12-0.11-0.010.22-0.090.14
0.1-0.490.420.46-0.430.38-0.010.23-0.16-0.160.85-0.29-0.15-0.350.72-0.12-0.040.2-0.360.12-0.710.270.00.520.2-0.74-0.050.80.280.6
0.370.270.250.210.360.310.180.270.05-0.25-0.150.430.350.59-0.360.420.50.790.510.30.40.070.0-0.06-0.270.50.810.040.1-0.12
0.26-0.350.380.50.150.380.090.21-0.53-0.170.650.08-0.57-0.040.670.130.520.410.040.22-0.630.310.52-0.060.02-0.38-0.210.66-0.440.69
-0.36-0.42-0.27-0.72-0.29-0.36-0.280.06-0.010.130.39-0.39-0.34-0.060.48-0.31-0.47-0.26-0.53-0.29-0.31-0.120.2-0.270.02-0.4-0.190.33-0.120.29
0.190.6-0.14-0.160.58-0.070.140.030.2-0.18-0.770.530.420.52-0.770.330.320.330.710.110.76-0.11-0.740.5-0.38-0.40.5-0.57-0.08-0.53
0.290.30.170.030.240.20.150.110.24-0.03-0.330.370.510.51-0.370.30.320.70.410.180.39-0.01-0.050.81-0.21-0.190.5-0.030.3-0.19
0.26-0.290.450.31-0.050.40.070.180.01-0.010.75-0.02-0.120.00.840.110.150.35-0.130.24-0.580.220.80.040.660.33-0.57-0.030.10.82
0.040.110.180.1-0.180.20.02-0.030.76-0.01-0.13-0.120.58-0.36-0.110.02-0.29-0.1-0.040.040.2-0.090.280.1-0.44-0.12-0.080.30.1-0.11
0.22-0.10.290.20.090.270.150.1-0.010.050.540.1-0.160.010.90.130.180.220.00.22-0.560.140.6-0.120.690.29-0.53-0.190.82-0.11
Click cells to compare fundamentals
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Competition

Novartis Long Term Debt To Capitalization

Long Term Debt To Capitalization

0.32

At this time, Novartis' Long Term Debt To Capitalization is comparatively stable compared to the past year.
Based on the recorded statements, the market capitalization of Novartis AG ADR is about 198.19 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The market capitalization for all United States stocks is significantly lower than that of the firm.

Novartis Market Capitalization Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novartis' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Novartis could also be used in its relative valuation, which is a method of valuing Novartis by comparing valuation metrics of similar companies.
Novartis is currently under evaluation in market capitalization category among related companies.

Novartis Fundamentals

About Novartis Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Novartis AG ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novartis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novartis AG ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. Novartis operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 108000 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Novartis AG ADR is a strong investment it is important to analyze Novartis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Novartis' future performance. For an informed investment choice regarding Novartis Stock, refer to the following important reports:
Check out Novartis Piotroski F Score and Novartis Altman Z Score analysis.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Complementary Tools for Novartis Stock analysis

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Is Novartis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
4.987
Dividend Share
3.919
Earnings Share
4.1
Revenue Per Share
22.467
Quarterly Revenue Growth
0.074
The market value of Novartis AG ADR is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novartis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.